FDA Awards Clearance to NeuroMetrix for Upgraded Quell
NeuroMetrix has scooped up FDA 510(k) clearance for an upgraded version of its Quell, an over-the-counter chronic pain relief wearable.
The device can be controlled directly by the Quell Relief smartphone app for patient convenience, the company says.
The new Quell device — which will be available in March — includes several additional improvements, including extended battery life and advanced sleep tracking.
NeuroMetrix is showcasing the device this week in Las Vegas, Nev. at the Consumer Electronics Show. — Michael Cipriano